Dr Sridevi Khambhampaty appointed as CEO of Shilpa Biologicals Ruchika Sharma20 Sept 2024 11:30 AM ISTKarnataka: Shilpa Medicare has announced the appointment of Dr Sridevi Khambhampaty, as Chief Executive Officer (CEO) of Shilpa Biologicals...
Intas Pharmaceutical Gets CDSCO Panel Nod to Study Atorvastatin plus Fenofibrate FDC Dr. Divya Colin17 July 2024 5:30 PM ISTNew Delhi: The drug major Intas Pharmaceutical has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard...
Intas Pharmaceuticals Gets CDSCO Panel Nod for Palatability Study of Temozolomide powder for oral suspension Dr. Divya Colin13 July 2024 6:00 PM ISTNew Delhi: The drug major Intas Pharmaceuticals has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard...
NPPA Fixes Retail Price Of 37 Formulations, Details Dr. Divya Colin24 May 2024 6:00 PM ISTNew Delhi: Through a recent notice, the National Pharmaceutical Pricing Authority (NPPA) has fixed the retail price of the 37 formulations under the...
Submit Periodic Safety Update Report In Indian Population: CDSCO Panel Tells Intas on rHumanErythropoeitinalfa injection Dr. Divya Colin22 March 2024 6:00 PM ISTNew Delhi: Reviewing the proposal presented by the drug major Intas Pharmaceuticals for the revision in package insertion of rh-EPO (r Human...
CDSCO Panel grants Intas Package Insert update for Pegfilgrastim solution for injection 6mg/0.6mL vial and PFS Dr. Divya Colin5 Feb 2024 6:00 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Center Drug Standard Control Organisation (CDSCO) has approved drug major Intas...
Intas Pharma Gets CDSCO Panel Nod to Study anti-cancer Drug Lipid Based Cabazitaxel Dr. Divya Colin1 Feb 2024 6:00 PM ISTNew Delhi: Citing that the firm should include an adequate number of government hospital trial sites, the Subject Expert Committee (SEC) functional...
CDSCO Panel grants Intas Pharma's proposal for additional pack of Romiplostim Injection 125 mcg/vial Dr. Divya Colin16 Jan 2024 5:30 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has approved the drug major...
Intas Pharma gets exclusive rights to commercialize Etanercept biosimilars in more than 150 countries across globe Ruchika Sharma25 Dec 2023 11:30 AM ISTAhmedabad: Intas Pharmaceuticals Ltd., a multinational pharmaceutical company, has announced a strategic exclusive licensing agreement with...
Intas Pharma gets USFDA warning letter due to manufacturing lapses at Ahmedabad plant Ruchika Sharma11 Dec 2023 11:30 AM IST"Repeated failures demonstrate that executive management oversight and control over the manufacture of drugs is inadequate," USFDA said.
CDSCO Drug Alert: 61 Drug Samples Including Emcure's Levocarnitine Inj Flagged Dr. Divya Colin24 Nov 2023 6:00 PM ISTNew Delhi: In its latest drug alert, the apex drug regulatory body, the Central Drugs Standard Control Organization (CDSCO), has flagged 61 medicine...
Intas Pharma to commercialise Serplulimab in India Ruchika Sharma30 Oct 2023 3:29 PM ISTSerplulimab will be commercialised by Intas in India and by its subsidiary, Accord Healthcare Ltd, in Europe.
